Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials
| Autor: | Fizazi, K. *, Flaig, T.W., Stöckle, M., Scher, H.I., de Bono, J.S., Rathkopf, D.E., Ryan, C.J., Kheoh, T., Li, J., Todd, M.B., Griffin, T.W., Molina, A., Ohlmann, C.H. |
|---|---|
| Zdroj: | In Annals of Oncology April 2016 27(4):699-705 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|